Genome-wide Association Study Identifies 27 Loci Influencing Concentrations of Circulating Cytokines and Growth Factors
- PMID: 27989323
- PMCID: PMC5223028
- DOI: 10.1016/j.ajhg.2016.11.007
Genome-wide Association Study Identifies 27 Loci Influencing Concentrations of Circulating Cytokines and Growth Factors
Abstract
Circulating cytokines and growth factors are regulators of inflammation and have been implicated in autoimmune and metabolic diseases. In this genome-wide association study (GWAS) of up to 8,293 Finns we identified 27 genome-widely significant loci (p < 1.2 × 10-9) for one or more cytokines. Fifteen of the associated variants had expression quantitative trait loci in whole blood. We provide genetic instruments to clarify the causal roles of cytokine signaling and upstream inflammation in immune-related and other chronic diseases. We further link inflammatory markers with variants previously associated with autoimmune diseases such as Crohn disease, multiple sclerosis, and ulcerative colitis and hereby elucidate the molecular mechanisms underpinning these diseases and suggest potential drug targets.
Copyright © 2017 American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.
Figures
Similar articles
-
Genome-wide Pleiotropy Between Parkinson Disease and Autoimmune Diseases.JAMA Neurol. 2017 Jul 1;74(7):780-792. doi: 10.1001/jamaneurol.2017.0469. JAMA Neurol. 2017. PMID: 28586827 Free PMC article.
-
Pathway-based Genome-wide Association Studies Reveal the Association Between Growth Factor Activity and Inflammatory Bowel Disease.Inflamm Bowel Dis. 2016 Jul;22(7):1540-51. doi: 10.1097/MIB.0000000000000785. Inflamm Bowel Dis. 2016. PMID: 27104816
-
Combinatorial effects of multiple enhancer variants in linkage disequilibrium dictate levels of gene expression to confer susceptibility to common traits.Genome Res. 2014 Jan;24(1):1-13. doi: 10.1101/gr.164079.113. Epub 2013 Nov 6. Genome Res. 2014. PMID: 24196873 Free PMC article.
-
Down the line from genome-wide association studies in inflammatory bowel disease: the resulting clinical benefits and the outlook for the future.Expert Rev Clin Immunol. 2015 Jan;11(1):33-44. doi: 10.1586/1744666X.2015.990439. Epub 2014 Dec 10. Expert Rev Clin Immunol. 2015. PMID: 25493555 Review.
-
Update on genetics in inflammatory disease.Best Pract Res Clin Gastroenterol. 2009;23(2):233-43. doi: 10.1016/j.bpg.2009.02.005. Best Pract Res Clin Gastroenterol. 2009. PMID: 19414149 Review.
Cited by
-
Exploring causal correlations between inflammatory cytokines and intervertebral disc degeneration: A Mendelian randomization.JOR Spine. 2024 Jul 10;7(3):e1349. doi: 10.1002/jsp2.1349. eCollection 2024 Sep. JOR Spine. 2024. PMID: 38993524 Free PMC article.
-
Genetically proxied IL-6 signaling and risk of Alzheimer's disease and lobar intracerebral hemorrhage: A drug target Mendelian randomization study.Alzheimers Dement (N Y). 2024 Aug 27;10(3):e70000. doi: 10.1002/trc2.70000. eCollection 2024 Jul-Sep. Alzheimers Dement (N Y). 2024. PMID: 39206334 Free PMC article.
-
Bidirectional Two-Sample Mendelian Randomization Analysis Reveals Causal Associations Between Modifiable Risk Factors and Fibromyalgia.J Pain Res. 2024 Oct 9;17:3297-3311. doi: 10.2147/JPR.S473101. eCollection 2024. J Pain Res. 2024. PMID: 39411195 Free PMC article.
-
Genetic perspectives on the influence of circulating cytokines on acne: A Mendelian randomization study.Medicine (Baltimore). 2023 Dec 15;102(50):e36639. doi: 10.1097/MD.0000000000036639. Medicine (Baltimore). 2023. PMID: 38115273 Free PMC article.
-
Causal relationships between systemic inflammatory cytokines and adhesive capsulitis: a bidirectional Mendelian randomization study.Front Immunol. 2024 Jun 24;15:1380889. doi: 10.3389/fimmu.2024.1380889. eCollection 2024. Front Immunol. 2024. PMID: 38979412 Free PMC article.
References
-
- Patsopoulos N.A., Esposito F., Reischl J., Lehr S., Bauer D., Heubach J., Sandbrink R., Pohl C., Edan G., Kappos L., Bayer Pharma MS Genetics Working Group. Steering Committees of Studies Evaluating IFNβ-1b and a CCR1-Antagonist. ANZgene Consortium. GeneMSA. International Multiple Sclerosis Genetics Consortium Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci. Ann. Neurol. 2011;70:897–912. - PMC - PubMed
-
- Jostins L., Ripke S., Weersma R.K., Duerr R.H., McGovern D.P., Hui K.Y., Lee J.C., Schumm L.P., Sharma Y., Anderson C.A., International IBD Genetics Consortium (IIBDGC) Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature. 2012;491:119–124. - PMC - PubMed
-
- Akdis M., Burgler S., Crameri R., Eiwegger T., Fujita H., Gomez E., Klunker S., Meyer N., O’Mahony L., Palomares O. Interleukins, from 1 to 37, and interferon-γ: receptors, functions, and roles in diseases. J. Allergy Clin. Immunol. 2011;127 701–21.e1, 70. - PubMed
-
- Nelson M.R., Tipney H., Painter J.L., Shen J., Nicoletti P., Shen Y., Floratos A., Sham P.C., Li M.J., Wang J. The support of human genetic evidence for approved drug indications. Nat. Genet. 2015;47:856–860. - PubMed
-
- Miller A.V., Ranatunga S.K.M. Immunotherapies in rheumatologic disorders. Med. Clin. North Am. 2012;96:475–496. ix–x. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
